Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

    Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi
    16-10-2025
    https://doi.org/10.4081/dr.2025.10588
    475
    PDF: 239
    HTML: 4
  • Erythrodermic psoriasis treated with apremilast

    John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul
    19-09-2016
    https://doi.org/10.4081/dr.2016.6599
    2223
    PDF: 994
    HTML: 614
  • Anisakis simplex and urticaria. What we know about its real incidence and management in dermatological settings?

    Sanja Javor, Donatella Bignardi, Matteo Borro, Cesare Massone
    29-08-2023
    https://doi.org/10.4081/dr.2023.9819
    1297
    PDF: 731
    HTML: 31
  • 67 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, USA; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, Canada; 5Chang Gung University College of Medicine, Taoyuan, Taiwan; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany; 8Department of Dermatology and Population Health Sciences, King’s College London, UK; 9Ada West Dermatology, St Luke’s Children’s Hospital Idaho, USA; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney, Australia; 11Eli Lilly and Company, Indianapolis, Indiana, USA; 12Almirall R&D, S.A., Barcelona, Spain; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11114
    133
    PDF: 68
  • Late reaction to ustekinumab infusion

    Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho
    e2
    09-09-2013
    https://doi.org/10.4081/dr.2013.e2
    4014
    PDF: 698
    HTML: 270
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1436
    PDF: 434
    HTML: 54
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1456
    PDF: 694
    HTML: 149
  • Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

    Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques
    11-09-2023
    https://doi.org/10.4081/dr.2023.9824
    1020
    PDF: 981
    HTML: 41
  • Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

    Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza
    23-11-2022
    https://doi.org/10.4081/dr.2022.9476
    1535
    PDF: 516
    HTML: 35
  • CD4/CD8 double-negative mycosis fungoides: a review

    Khalid Nabil Nagshabandi, Abdulrahman Shadid, Asem Shadid, Nouf K. Almuhanna
    12-04-2024
    https://doi.org/10.4081/dr.2024.9908
    3339
    PDF: 663
    SUPPLEMENTARY: 133
    HTML: 37
  • Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

    Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi
    21-02-2025
    https://doi.org/10.4081/dr.2025.10278
    513
    PDF: 333
    HTML: 27
  • Association of single-nucleotide NR3C1 gene polymorphisms with glucocorticosteroid responsiveness in patients with pemphigus vulgaris

    Thai Van Thanh Le, Duy Quan Nguyen, Ngoc Dang Tran, Hoang Kim Tu Trinh
    05-10-2021
    https://doi.org/10.4081/dr.2021.9190
    4209
    PDF: 578
    HTML: 14
  • Herpes vegetans, an atypical herpes lesion in HIV patient: A case report

    Sondang P. Sirait, Wresti Indriatmi
    14-03-2022
    https://doi.org/10.4081/dr.2022.9180
    2762
    PDF: 906
    HTML: 26
  • The first reported case of erythrodermic sarcoidosis with systemic involvement during COVID-19 vaccination

    Georgi Tchernev, Simona Kordeva, Heily Kirilova, Valentina Broshtilova
    01-03-2023
    https://doi.org/10.4081/dr.2023.9636
    1297
    PDF: 624
    HTML: 77
  • Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

    Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili
    13-03-2025
    https://doi.org/10.4081/dr.2025.10021
    549
    PDF: 372
    HTML: 16
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

    Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino
    25-06-2020
    https://doi.org/10.4081/dr.2020.8642
    1428
    PDF: 778
    HTML: 19
  • Exacerbation of generalized plaque psoriasis after tuberculin test

    Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Walter Volpi, Marzia Caproni
    28-07-2021
    https://doi.org/10.4081/dr.2021.9019
    3217
    PDF: 536
    HTML: 311
  • Does the response to bimekizumab vary according to previous therapy with methotrexate versus cyclosporine?

    Ilaria Salvi, Alexandra M. G. Brunasso, Franco Castelli, Andrea Michelerio, Paolo Pella, Marco Rubatto, Paolo Dapavo, Emanuele Cozzani, Martina Burlando
    20-03-2026
    https://doi.org/10.4081/dr.2026.10236
    372
    PDF: 313
  • A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

    Lorry Aitkens, Joel Byrne, Charay Jennings-Dover, Kathryn Anne Potter
    29-12-2022
    https://doi.org/10.4081/dr.2023.9634
    986
    PDF: 503
    HTML: 132
  • 29 | INNOVATIVE THERAPEUTIC STRATEGIES IN GENODERMATOSIS: AN ITALIAN MULTICENTRE STUDY F. Pavan1, F. Cassalia2, S. Giordano3, A. Gelmetti4, L. Ventura5, F. Caroppo2, A. Bassi6, F. Martorana7, R. Balestri8, A. Guglielmo9, F. Ambrogio10, A. Bonvicino3, I. Neri4, P. Quaglino3, A. Belloni Fortina11 | 1Pediatrics Unit, Department of Women’s and Child’s Health (SDB), University of Padua, Italy; 2Dermatology Unit, Department of Medicine (DIMED), University of Padua, Italy; 3Department of Medical Sciences, Section of Dermatology, University of Turin, Italy; 4Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Italy; 5Department of Statistical Science, University of Padua, Italy; 6Unit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy; 7Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II; 8Division of Dermatology, Outpatient Consultation for Rare Diseases, APSS, Trento, Italy; 9Institute of Dermatology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy; 10Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, Italy; 11Pediatric Dermatology Department of Women’s and Child’s Health (SDB), University of Padua, Italy

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11091
    107
    PDF: 31
  • A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

    Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang
    12-04-2024
    https://doi.org/10.4081/dr.2024.9899
    1026
    PDF: 630
    HTML: 33
  • Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument

    Ashjan Alheggi, Raneem Alnutaifi, Manal Alkhonezan, Norah Almudawi, Renad Alsuhaibani, Philip Moons, Turki Aljuhani
    18-05-2023
    https://doi.org/10.4081/dr.2023.9700
    1224
    PDF: 403
    APPENDIX S1: 220
    HTML: 20
  • Molluscum contagiosum eruption during therapy with methotrexate and abatacept: a clinical and dermoscopic case study

    Franca Taviti, Alessandra Calcinai, Federica Scarfì
    21-03-2022
    https://doi.org/10.4081/dr.2022.9259
    1169
    PDF: 558
    HTML: 581
  • Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis

    Davide Bertolla, Andrea Conti
    30-01-2026
    https://doi.org/10.4081/dr.2026.10240
    1065
    PDF: 460
  • 31 | DRUG ECONOMIC ANALYSIS OF THE DOSE SPACING OF BIOLOGICAL DRUGS IN ATOPIC DERMATITIS AND PSORIASIS A. Filoni1, L. Pietroleonardo1, P. Stasi2, M. Spagnolo2, F. Scicchitano2, S. Pelle3, M. Congedo1 | 1UOSVD Dermatology and Allergology, Hospital Vito Fazzi, Lecce, Italy; 2Servizio Farmaceutico Distrettuale. Asl Lecce, Italy; 3Dermatology Outpatient Unit, Asl Lecce, Italy

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11064
    98
    PDF: 39
26 - 50 of 50 items << < 1 2 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.